Sio Gene Therapies | SC 13G/A:超过5%持股股东披露文件(修正)-Suvretta Capital Management, LLC(0%),Averill Master Fund, Ltd.(0%)等
Sio Gene Therapies | SC 13G:超过5%持股股东披露文件-Rubric Capital Management LP(9.46%),David Rosen(9.46%)
Sio Gene Therapies | SC 13G/A:超过5%持股股东披露文件(修正)-Consonance Capital Management LP(0%),Mitchell Blutt(0%)等
Sio Gene Therapies | SC 13G/A:超过5%持股股东披露文件(修正)-Suvretta Capital Management, LLC(8.1%),Averill Master Fund, Ltd.(8.1%)等
Sio Gene Therapies | 4:持股变动声明
Sio Gene Therapies | 4:持股变动声明
Sio Gene Therapies | 3:首次持股声明-首席商务官 Meswani Parag V
Sio Gene Therapies | 4:持股变动声明
Sio Gene Therapies | 4:持股变动声明
Sio Gene Therapies | 4:持股变动声明
Sio Gene Therapies | 4:持股变动声明
Sio Gene Therapies | 4:持股变动声明
Sio Gene Therapies | 4:持股变动声明
Sio Gene Therapies | 4:持股变动声明
Sio Gene Therapies | 4:持股变动声明
Sio Gene Therapies | 4:持股变动声明
Sio Gene Therapies | 4:持股变动声明
Sio Gene Therapies | 4:持股变动声明
Sio Gene Therapies | 4:持股变动声明
Sio Gene Therapies | 4:持股变动声明
暂无数据